[1]孙春雷,牟妍,金仙花,等.司库奇尤单抗成功治疗难治性斑块型银屑病1例[J].中国皮肤性病学杂志,2020,(10):1216-1217.[doi:10.13735/j.cjdv.1001-7089.202002031]
点击复制

司库奇尤单抗成功治疗难治性斑块型银屑病1例()
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2020年10期
页码:
1216-1217
栏目:
短篇
出版日期:
2020-10-01

文章信息/Info

文章编号:
1001-7089(2020)10-1216-02
作者:
孙春雷牟妍金仙花朱文静夏建新
吉林大学第二医院皮肤科,吉林 长春 130000
分类号:
R 758.63
DOI:
10.13735/j.cjdv.1001-7089.202002031
文献标志码:
B

参考文献/References:

[1] 王金校.阿维A治疗68例儿童重症银屑病的疗效及安全性分析[J].中国皮肤性病学杂志,2011,25(11):861-862.
[2] Giuseppe P,Nicola P,Valentina C,et al.A case of moderate hidradenitis suppurativa and psoriasis treated with secukinumab[J].Ann Dermatol,2018,30(4):462-464.
[3] Galluzzo M,D'Adamio S,Bianchi L,et al.Psoriasis in pregnancy:case series and literature review of data concerning exposure during pregnancy to ustekinumab[J].J Dermatol Treat,2019,30(1):40-44.
[4] Frieder J,Kivelevitch D,Menter A.Secukinumab:a review of the anti-IL-17A biologic for the treatment of psoriasis[J].Ther Adv Chronic Dis,2018,9(1):5-21.
[5] Cesare AD,Meglio PD,Nestle FO.The IL-23/Th17 axis in the immunopathogenesis of psoriasis[J].J Invest Dermatol,2009,129(6):1339-50.
[6] Schadler ED,Ortel B,Mehlis SL.Biologics for the primary care physician:Review and treatment of psoriasis[J].Dis Mon,2019,65(3):51-90.
[7] Thaçi D,Blauvelt A,Reich K,et al.Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis:CLEAR,a randomized controlled trial[J].J Am Acad Dermatol,2015,73(3):400-409.
[8] Blauvelt A,Reich K,Tsai TF,et al.Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year:Results from the CLEAR study[J].J Am Acad Dermatol,2017,76(1):60-69.
[9] 中华医学会皮肤性病学分会,中国医师协会皮肤科医师分会,中国中西医结合学会皮肤性病专业委员会.中国银屑病生物治疗专家共识(2019)[J].中华皮肤科杂志,2019,52(12):863-871.

备注/Memo

备注/Memo:
[基金项目] 吉林省科技厅(20190303172SF)
[通信作者] 夏建新,E-mail:911469806@qq.com
更新日期/Last Update: 2020-10-15